alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
From: andrewdds@sbcglobal.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 12:07:18 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Andy Doerfler

Spring, TX 77379
[Cite as State ex rel. Sevayega v. McMonagle, 122 Ohio St.3d 54, 2009-Ohio-2367.]

THE STATE EX REL. SEVAYEGA, APPELLANT, v. MCMONAGLE,

JUDGE, APPELLEE. 

[Cite as State ex rel. Sevayega v. McMonagle, 

 122 Ohio St.3d 54, 2009-Ohio-2367.]

Appeal from dismissal of a petition for a writ of procedendo – Procedendo not 

available to compel performance of a duty already performed – Judgment 

affirmed. 

(No. 2009-0106 ─ Submitted May 19, 2009 ─ Decided May 28, 2009.) 

APPEAL from the Court of Appeals for Cuyahoga County, 

No. 92157, 2008-Ohio-6275. 

____________________ 

Per Curiam.

{¶ 1} We affirm the judgment of the court of appeals dismissing the 

complaint of appellant, Reginald D. Sevayega, for a writ of procedendo. A writ 

of procedendo will not issue to compel the performance of a duty that has already 

been performed. State ex rel. Howard v. Skow, 102 Ohio St.3d 423, 2004-Ohio3652, 811 N.E.2d 1128, ¶ 9. Moreover, insofar as Sevayega contests the 

propriety of the ruling he received on his postconviction motion, he had an 

adequate remedy in the ordinary course of law by way of appeal. Extraordinary 

relief in procedendo will not be granted if there is an adequate remedy in the 

ordinary course of law. State ex rel. George v. Burnside, 118 Ohio St.3d 406, 

2008-Ohio-2702, 889 N.E.2d 533, ¶ 7. 

Judgment affirmed. 

 MOYER, C.J., and PFEIFER, LUNDBERG STRATTON, O’CONNOR,

O’DONNELL, LANZINGER, and CUPP, JJ., concur. 

____________________ 
SUPREME COURT OF OHIO

2 

 Reginald D. Sevayega, pro se. 

 William D. Mason, Cuyahoga County Prosecuting Attorney, and Pamela 

Bolton, Assistant Prosecuting Attorney, for appellee. 

 D. Jim Brady, amicus curiae. 

____________________
EXHIBIT 23
                                                                         
                   CONSENT OF INDEPENDENT ACCOUNTANTS
                                    
We hereby consent to the incorporation by reference in the Prospectus
constituting part of the Registration Statement on Form S-3 (No.33-59267) of
Caterpillar Financial Services Corporation of our report dated 
January 18, 1996 appearing on Page 15 of this Form 10-K.





PRICE WATERHOUSE LLP


New York, New York
March 21, 1996
No. 63283.

protests 58/22311(B) and 58/24630(A) (New York).

#### Judson Sheldon International and National Carloading Corporation *v.*United States,

Opinion by

Lawrence, J.

The protests were dismissed.
No. 314.

#### Hoffa et al. *v.*United States.

*Jacob Kossman, Charles E. Davis*and *0. B. Cline, Jr.*for petitioners.

*Solicitor General Cox, Assistant Attorney General Miller, Robert S. Erdahl*and *Marie L. McCann*for the United States.

C. A. 5th Cir. Certiorari denied.

Mr. Justice White and Mr. Justice Goldberg took no part in the consideration or decision of this petition.
From: paulkeith@postpro.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 1:05:25 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

This is the United States where government is by and for the people. The people have a conscience

and the federal government should never require the people to act outside of their individual

conscience. You should be striving to protect the right of the people to individual thought instead of

seeking to override the right of the people to think and act according to their individual beliefs. Again I

urge you to reword RIN 1210-AB44 to allow all people to provide or acquire insurance according to their

individual consciences.

Sincerely,

PAUL KEITH

Pensacola, FL 32505
#### UNITED STATES of America, Plaintiff-Appellee, v. J. Guadalupe RAMOS-ESPINO, also known as Guadalupe Ramos, also known as J. Guadalupe Ramos, also known as Guadalupe Ramos-Espino, Defendant-Appellant.

No. 05-50233.

Conference Calendar.

United States Court of Appeals, Fifth Circuit.

Decided Aug. 17, 2005.

Joseph H. Gay, Jr., Assistant U.S. Attorney, U.S. Attorney’s Office, Western *338District of Texas, San Antonio, TX, for Plaintiff-Appellee.

Henry Joseph Bemporad, Federal Public Defender’s Office, Western District of Texas, San Antonio, TX, for Defendant Appellant.

Before BENAVIDES, CLEMENT, and PRADO, Circuit Judges.

PER CURIAM: *

Appealing the Judgment in a Criminal Case, J. Guadalupe Ramos-Espino raises arguments that are foreclosed by *Almendarez-Torres v. United States,*523 U.S. 224, 235, 118 S.Ct. 1219, 140 L.Ed.2d 350 (1998), which held that a prior conviction is a sentencing factor under 8 U.S.C. § 1326(b)(2) and not a separate criminal offense. The Government’s motion for summary affirmance is GRANTED, and the judgment of the district court is AFFIRMED.

*

 Pursuant to 5th Cir. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.
<PAGE>



                                                                    Exhibit 23.2

               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS



We consent to the incorporation by reference in the Registration Statements on
Form S-8 pertaining to Cover-All Technologies Inc. Amended and Restated 2005
Stock Incentive Plan, of our report dated March 27, 2007, with respect to the
consolidated financial statements of Cover-All Technologies Inc. included in its
Annual Report [Form 10-K] for the year ended December 31, 2006, filed with the
Securities and Exchange Commission.








                                                    /s/ Moore Stephens, P.C.
                                                    ------------------------
                                                    MOORE STEPHENS, P. C.
                                                    Certified Public Accountants

New York, New York
April 2, 2007
Exhibit 31(b)

 

Section 302 Certifications

 

| Certifications |  |
|----------------|--|

I, Lori A. Hickok, certify that:

| 1. | I have reviewed this annual report on Form 10-K/A of Scripps Networks Interactive, Inc.; |
|----|------------------------------------------------------------------------------------------|

| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3. | [Intentionally omitted] * |
|----|---------------------------|

| 4. | [Intentionally omitted] * |
|----|---------------------------|

| 5. | [Intentionally omitted] * |
|----|---------------------------|

 

| Date: March 6, 2018                                                 |   |   |
|---------------------------------------------------------------------|--------|--------|
| BY:                                                                 |   |   |
| /s/ Lori A. Hickok                                                  |   |   |
| Lori A. Hickok                                                      |   |   |
| Executive Vice President, Chief Financial and 

Development Officer |   |   |

 

 

*Paragraphs 3 through 5, omitted here, are included in Exhibit 31.B to the Annual Report on Form 10-K filed by Scripps Networks Interactive, Inc. on February 27, 2018.
[Federal Register Volume 88, Number 172 (Thursday, September 7, 2023)]
[Notices]
[Pages 61605-61606]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-19261]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of General Medical 
Sciences Initial Review Group; Training and Workforce Development 
Study Section--A Review of Applications for Medical Scientist 
Training Program and Basic Biomedical Predoctoral T32 awards.
    Date: October 16-17, 2023.
    Time: 8:30 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Bethesdan Hotel, Tapestry Collection by Hilton, 8120 
Wisconsin Avenue, Bethesda, Maryland 20892 (Hybrid Meeting).
    Contact Person: Isaah S. Vincent, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Institute of General 
Medical Sciences, National Institutes of Health, 45 Center Drive, 
Room 3AN12L, Bethesda, Maryland 20892, 301-594-2948, 
<a href="/cdn-cgi/l/email-protection#1d746e7c7c75336b74737e7873695d737475337a726b"><span class="__cf_email__" data-cfemail="254c5644444d0b534c4b46404b51654b4c4d0b424a53">[email protected]</span></a>.

    Information is also available on the Institute's/Center's home 
page: www.nigms.nih.gov/, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program No. 93.859, 
Biomedical Research

[[Page 61606]]

and Research Training, National Institutes of Health, HHS)

    Dated: August 31, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-19261 Filed 9-6-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
No. 69, Misc.

#### Wheeldin et al. *v.*Wheeler.

*A. L. Wirin, Fre.d Okrand*and *Nanette Dembitz*for petitioners.

*Solicitor General Cox, Acting Assistant Attorney General Guilfoyle*and *John G. Laughlin, Jr.*for respondent.

Motion for leave to proceed *in forma pauperis*and petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit granted. Case transferred to the appellate docket. In briefs and oral argument, counsel are directed to discuss the question of federal jurisdiction.
[Federal Register Volume 88, Number 180 (Tuesday, September 19, 2023)]
[Notices]
[Page 64448]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-20158]



[[Page 64448]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Asthma 
Education Prevention Program Coordinating Committee.
    The meeting will be held as a virtual meeting and is open to the 
public. Individuals who plan to attend and need special assistance, 
such as sign language interpretation or other reasonable accommodations 
to view the meeting, should notify the Contact Person listed below in 
advance of the meeting. The meeting can be accessed from the NIH 
Videocast at the following link: https://videocast.nih.gov/watch=52355.

    Name of Committee: National Asthma Education Prevention Program 
Coordinating Committee
    Date: September 22, 2023.
    Time: 11:00 a.m. to 2:00 p.m.
    Agenda: Programmatic and Scientific Updates.
    Place: National Institutes of Health, Rockledge II, 6705 
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
    Virtual Access: https://videocast.nih.gov/watch=52355.
    Contact Person: Susan Shero, MS, Program Officer, Center for 
Translational Research and Implementation Science, National Heart, 
Lung, and Blood Institute, National Institutes of Health, 6705 
Rockledge Drive, Bethesda, MD 20892, 301-496-1051, 
<a href="/cdn-cgi/l/email-protection#4c3f393f2d22623f24293e230c222524622b233a"><span class="__cf_email__" data-cfemail="44373137252a6a372c21362b042a2d2c6a232b32">[email protected]</span></a>.

    This notice is being published less than 15 days prior to the 
meeting due to scheduling conflicts.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's 
homepage: https://www.nhlbi.nih.gov/advisory-and-peer-review-committees/national-asthma-education-and-prevention-program-coordinating, where an agenda and any additional information for the 
meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: September 13, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-20158 Filed 9-18-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit
32.1<?xml:namespace
      prefix = o ns = "urn:schemas-microsoft-com:office:office"
      />









AEROCENTURY CORP.









Certification














In connection with this quarterly
report of AeroCentury Corp.
(the “Company”) on Form 10-Q for the period ended March 31, 2008 as filed
with the Securities and Exchange Commission (the “Report”), I, Neal D. Crispin,
Chief Executive Officer of the Company, hereby certify as of the date hereof,
solely for purposes of Title 18, Chapter 63, Section 1350 of the United States
Code, that to the best of my knowledge:









(1)  the Report fully
complies with the requirements of Section 13(a) or 15(d), as applicable, of the
Securities Exchange Act of 1934, and









(2)  the information
contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company at the dates and for the
periods indicated.









This Certification has not been, and
shall not be deemed, “filed” with the Securities and Exchange Commission.









Date
      May 15. 2008
            
            /s/ Neal
      D. CrispinName: 
      Neal D. CrispinTitle: 
      President & CEO
Exhibit 4.7


 





 


THE SYMBOL "****" DENOTES
PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL HAS BEEN
FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.


 


August 6, 2010


 


ProSeed Capital Holdings CVA


Vlierbeekberg 107


3090 Overijse, Belgium


 


Re: Termination of Fee Agreement


 


Dear Sirs:


 


In accordance with Section
4 of the Fee Agreement between us dated June 3, 2010, RedHill Biopharma Ltd. hereby notifies you of termination of the Fee Agreement
effective thirty (30) days following the date of this letter.


 


Exhibit A annexed hereto
identifies the "Introduced Parties" under the Agreement through the date of termination.


 


Please indicate your agreement
with and acceptance of the foregoing in the space provided below.


 





	 	Respectfully,	 
	 	 	 
	 	/s/ Ori Shilo	 
	 	RedHill Biopharma Ltd.	 







  


AGREED TO AND ACCEPTED:


  


	/s/ Benjamin Van-Oudenhove	 
	ProSeed Capital Holdings CVA	 




 


142 Givati St., Ramat-Gan 52232 Israel


Phone: +972-3-676 1706 Fax: +972-3-725 5723


 



    	1



    	 



    




 


Exhibit 4.7


 





 


EXHIBIT A


 


Introduced Parties Through Date of Termination


 


[****]


 


142 Givati St., Ramat-Gan 52232 Israel


Phone: +972-3-676 1706 Fax: +972-3-725 5723


 



    	2
*Pursuant to Local Rule 47.5, the court has determined that

this opinion should not be published and is not precedent except

under the limited circumstances set forth in Local Rule 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

____________________

No. 96-60442

Summary Calendar

____________________

RODNEY BELL,

Plaintiff-Appellant,

versus

RAYMOND ROBERTS,

Defendant-Appellee.

_________________________________________________________________

Appeal from the United States District Court for the

Northern District of Mississippi

 (4:96CV189-S-B) 

________________________________________________________________

November 6, 1996

Before GARWOOD, JOLLY, and DENNIS, Circuit Judges.

PER CURIAM:*

In this case, the plaintiff alleges no basis for a claim of

denial of constitutional due process. His pleadings reflect that

he is essentially dissatisfied with the result of the disciplinary

proceedings. In addition, he alleges only in the most general

terms that the defendants’ decisions violated his rights (which

were undescribed) and that the decisions were against the weight of
the evidence. These allegations do not rise to the level of

stating a section 1983 claim, and such bare allegations do not

require a Spears’ hearing to develop the claim. See Spears v.

McCotter, 766 F.2d 179, 181 (5th Cir. 1985). The judgment of the

district court, dismissing the complaint is therefore 

A F F I R M E D.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                          11,124
<SECURITIES>                                         0
<RECEIVABLES>                                   28,712
<ALLOWANCES>                                       405
<INVENTORY>                                     25,236
<CURRENT-ASSETS>                                70,019
<PP&E>                                          51,102
<DEPRECIATION>                                  24,156
<TOTAL-ASSETS>                                  98,328
<CURRENT-LIABILITIES>                           21,525
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           592
<OTHER-SE>                                      71,180
<TOTAL-LIABILITY-AND-EQUITY>                    98,328
<SALES>                                        179,628
<TOTAL-REVENUES>                               179,628
<CGS>                                          137,709
<TOTAL-COSTS>                                  137,709
<OTHER-EXPENSES>                                25,783
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 622
<INCOME-PRETAX>                                 16,217
<INCOME-TAX>                                     5,625
<INCOME-CONTINUING>                             10,592
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    10,592
<EPS-PRIMARY>                                     1.15
<EPS-DILUTED>                                     1.15
        

</TABLE>